International proprietary funding agency Eight Roads Ventures, which is backed by Constancy, has appointed Shirish Belapure as a Enterprise Accomplice. Belapure joins Harvinderjit Singh Bhatia and Deepak Kanvinde who work alongside Eight Roads’ funding staff in India to drive potential investments, develop the Eight Roads community, and assist the prevailing portfolio.
Shirish is an skilled and well-regarded pharmaceutical skilled having spent 42 years within the trade. He was the Managing Director at Zydus Hospira Oncology Pvt. Ltd. Additional, he’s additionally a Senior Technical Advisor on the Indian Pharmaceutical Alliance (IPA) the place he advises and helps the actions of the High quality Discussion board.
[Funding alert] B2B startup MoEngage raises $25M in Collection C led by Eight Roads Ventures
Shirish Belapure added, “Eight Roads is an ideal accomplice for the most recent era of healthcare entrepreneurs who need to construct massive, lasting corporations that leverage expertise breakthroughs, enterprise mannequin innovation, and global-mindset. I sit up for working alongside these corporations and being a part of their journey.”
Launched in 2007, Eight Roads has invested in over 40 corporations throughout healthcare, expertise, client, and monetary providers. It’s dedicated to creating the businesses it invests in leaders of their industries via entry to affected person capital, a strong community of assets, and a staff of funding professionals with a confirmed observe report of success.
Prem Pavoor, Accomplice at Eight Roads Ventures, stated, “We’re privileged to accomplice with distinctive founders who proceed to push the boundaries of innovation and construct world-class healthcare companies. We welcome Belapure to the staff, his deep expertise throughout the pharmaceutical provide chain will add immense worth to our accomplice corporations.”
By its community of advisors, Eight Roads sees a possibility to assist founders with the expertise that these professionals convey together with their deep technical and operational experience and powerful trade networks.
Eight Roads Ventures’ present and exited healthcare investments in India and Southeast Asia embody Ashish Life Science, Caplin Steriles, Carestack, Cipla Well being, Core Diagnostics, Cygnus Hospitals, eKincare, Eywa Pharma, Immuneel Therapeutics, Laurus Labs, Medwell Ventures, Plasmagen Biosciences, Pharmeasy, Richcore Lifesciences, Specsmakers, and Trivitron Healthcare.
(Edited by Suman Singh)